Patent
Acts Considered as Violation against FRAND in SEP Negotiation
2022-02-17
  Linda Liu Partners IGuidance Documents In recent years, SEP (standard essential patent) has become a hot topic worldwide as huge commercial interests are involved. Whether an injunction can be granted in litigation concerning SEP has been u
Latest Change in Chinese Examination of Utility Model Patent
2022-02-17
  Linda Liu Partners In recent years, Chinese utility model patent has attracted attention of numerous domestic and foreign applicants due to low cost, rapid granting and no strict limitations as in German and Japan. The amount of patent appl
On Invalidation of the Patent “Pharmaceutical Composition Comprising Valsartan and NEP Inhibitors” No. 201110029600.
2022-02-17
  Yan WANG Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners On September 15, 2017, the Reexamination Board performed oral proceedings for request for invalidation No. 4W105696. This is the fifth case included in t
Preliminary Study on Determination of Equivalent Infringement in China
2022-02-17
  Hank SHEN Chinese Patent Attorney Mechanical Engineering Department Linda Liu Partners The infringement of invention and utility model patents (hereinafter referred to as patents) in China includes literal infringement and equivalent infrin
Response to Office Action on Claims of Purified Product Defined by Feature of Use
2022-02-17
  Ran DUAN Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners In some product claims, the product is defined by a feature of use. Although the limiting effect of the feature of use to the product remains disputable,
How We Should Write Claims of Biological Sequences to Get Favors from Examiners and Judges
2022-02-18
  Wenhan LIU Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners In Chinas patent practice, people have been contending about ways of writing a claim of a biological sequence that could balance between interests of t
A Brief Analysis of the Reply to Office Actions Aimed at Claims of “Product by Process” by Briefing a Re-examination
2022-02-18
  Guangping ZHANG Chinese Patent Attorney Electrical Engineering Department Linda Liu Partners I. Introduction A product claim should be defined by its own technical features as much as possible, for example, using a static structure (namely,
A Reexamination Case Taught Us How to Avoid Going beyond the Scope
2022-02-18
  Hao ZHANG Chinese Patent Attorney As Rule 42.1 of the Implementing Regulations of the Chinese Patent Law says, where an application for a patent contains two or more inventions, utility models or designs, the applicant may, before the expir
A Study on a Utility Model Case in Electrical Field
2022-02-18
  Lei ZHOU Chinese Patent Attorney Linda Liu Partners I. Special Problems faced by Technical Solutions in Electrical Field in the Application for Utility Model in China Utility model is one of the three patent types in China and favored by ap
Discussion on the Distribution of Burden of Proof in Presumption of Novelty about Drug Crystal Forms
2022-02-18
  Yu BAI Chinese Patent Attorney Chemistry Biotechnology Department Linda Liu Partners In the context of the booming pharmaceuticals industry, patents for crystal forms of pharmaceutical compounds are playing a more and more important role. F
About us | Contact us | Favorite | Home Page
LINKS:Beijing Wei Chixue Law Firm
©2008-2025 By Linda Liu & Partners, All Rights Reserved.